mail
versión imprimible
 
 

2nd Integrin-Targeted Drug Development Summit

Evvnt Promotion / evvnt
-
31.08.2022 - 01.09.2022  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 08:30 - 16:00
 
Temas de la conferencia
Over the last 12 months, the industry has witnessed promising data and candidates entering the clinic. 7 Hills Pharma, Corbus Pharmaceuticals, Vincerx, and Morphic are paving the way to develop a safe, efficacious integrins-targeted drug to modify disease biology, which will be a game-changer for diseases such as oncology, autoimmune, and ophthalmology, with unmet medical needs.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/1173725-3?pid=4832

Speakers: Bernhard Wehrle-Haller, Professor, Geneva University, Bruce Rogers, President, Morphic Therapeutics, Darren G. Woodside, Vice President of Research, Texas Heart Institute, and more.
 

Información e inscripción:

https://go.evvnt.com/1173725-2?pid=4832
Ms. Erin Thomas
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 5696.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Center of ExcellenceEuropean Health Forum GasteinHilfswerk AustriaSwiss Tropical and Public Health InstituteAGEM - Arbeitsgemeinschaft Ethnologie und MedizinnewTreeCharité International AcademyAlumni Club Medizinische Universität Wien